Clinical Trials in Denver

Showing 8081-8100 of 13,773 trials

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

NCT00833326

This is a Phase 1 study during which patients with advanced/metastatic solid tumors will receive investigational study drug ARRY-334543 and docetaxel (with prophylactic growth factor support). Patients will receive increasing doses of study drug in combination with docetaxel in order to achieve the highest dose of study drug possible that will not cause unacceptable side effects. Patients will be followed to see what side effects the combination causes and what effectiveness the combination has, if any, in treating the cancer. Approximately 30 patients from the US will be enrolled in this study.

Advanced Cancer

Array Biopharma, now a wholly owned subsidiary of Pfizer27 participantsStarted Jan 2009

Aurora, Colorado, United States • Rochester, Minnesota, United States • Nashville, Tennessee, United States

COMPLETEDPhase 38.4 miles

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

NCT00014222

RATIONALE: 1. . To compare the effects on breast cancer of three different combinations of drugs which are commonly used to treat this disease. 2. . It is not yet known which treatment regimen is most effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.

Breast Cancer

NCIC Clinical Trials Group2,104 participantsStarted Dec 2000

Fort Smith, Arkansas, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +75 more locations

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Find Trials by Condition in Denver

A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer

EVOLVE Short DAPT Study

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Subcutaneous Fat Reduction in the Submental Area

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene